Candesartan Cilexetil and Rosuvastatin Tablets 5/16 mg

Adult dose

Candesartan Cilexetil 1. Essential Hypertension - The recommended starting and maintenance dose is 8 to 16 mg orally once daily. - If blood pressure remains uncontrolled after 4 weeks of treatment at 16 mg once daily, it can be increased to a maximum of 32 mg once daily. - In patients with decreased effective blood volume or renal impairment, the initial dose is 4 mg. - In patients with mild to moderate liver impairment, the initial dose is 2 mg once daily. 2. Heart Failure

Child dose

The safety and efficacy in adolescents and children under 18 years have not been established.

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, if pregnancy is confirmed, it should be discontinued immediately. This medication should not be given to patients with certain liver diseases, severely impaired kidney function, muscle disease history, and genetically induced lactose intolerance. Caution should be exercised in the elderly, patients with hyperkalemia, and those with compromised liver function while using this medication, and regular blood tests should be conducted to monitor their condition if necessary. If symptoms such as muscle pain or weakness occur, consult a doctor immediately; if blood markers indicating muscle damage increase along with these symptoms, the medication should be stopped. This medication may affect liver function; therefore, liver enzyme levels should be checked before and during administration, and if abnormalities are found, treatment should be discontinued. There is a risk of excessively low blood pressure or worsening kidney function, so especially in patients with heart failure or renal impairment, blood pressure and kidney function should be monitored regularly during administration. There may be interactions with other medications, so if you are taking any other medications, you must inform your doctor or pharmacist. Women of childbearing potential should use appropriate contraceptive methods while taking this medication, and breastfeeding women should avoid taking it or discontinue breastfeeding. The safety and efficacy of this medication have not been established in children and is not recommended. In case of overdose, appropriate treatment is required depending on the symptoms, and as there is no specific antidote, symptom management and monitoring are crucial. Dizziness or lethargy may occur while taking this medication; therefore, caution is advised when driving or operating machinery. Keep this medication out of reach of children and do not transfer it to another container for safety.

Serious side effects

Hives, severe swelling (edema), angioedema, shock, syncope, loss of consciousness, rash, Stevens-Johnson syndrome, eosinophilia and systemic symptoms drug reaction syndrome (DRESS), jaundice, hepatitis, acute renal failure, increased serum creatinine, thrombocytopenia, cerebrovascular accident, inflammatory spinal cord disease, pneumonia, unstable angina, idiopathic pulmonary fibrosis, worsening hypertension, vertigo, postural vertigo, adrenal insufficiency, blood pressure increase

Mild side effects

• Headache
• dizziness
• positional dizziness
• nasopharyngitis
• papules
• local infections
• periodontitis
• chest discomfort
• fatigue
• inflammation

This medication should be stored in a tightly sealed container to protect it from exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Pink round film-coated tablets

Package unit

30 tablets/box [10 tablets/PTPX3]